Agcakaya E, Mutlu HH, Erbakan A, Sargin M
doi: 10.1016/j.cmet.2017.06.005 79 HuangHCChenLZhangHXLiSFLiuPZhaoTYet al
1068 Quality of Life in the Early Period After Allogeneic Hematopoietic Stem Cell Transplantation: Dynamics and the Impact of GVHD Gabriela Lampart 1 , Agnieszka Gniadek 2 , Beata Pitkowska - Jakubas 3 1 Jagiellonian University Medical College, Doctoral School of Medical and Health Sciences, Krakow, Poland, 2 Jagiellonian University Medical College, Faculty of Health Sciences, Institute of Nursing and Midwifery, Krakow, Poland, 3 Jagiellonian University Medical College, Faculty of Medicine, Chair of Hematology, Krakow, Poland Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :1068 Aims Quality of life (QoL) is a crucial aspect of recovery following allogeneic hematopoietic stem cell transplantation (allo-HSCT)
Other type 2 diabetes medications also promote weight loss, but to a lesser extent
structure }( coaPopupData } errors[0] errors[0] LGC will use your email address only for the purposes of providing the requested document
Most initiators who had T2D also had a clear medical indication for intensification of glucose-lowering medication, based on glucose levels and/or comorbidities